0001693587-19-000003.txt : 20190315 0001693587-19-000003.hdr.sgml : 20190315 20190315115840 ACCESSION NUMBER: 0001693587-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190315 DATE AS OF CHANGE: 20190315 EFFECTIVENESS DATE: 20190315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vitruvian BioMedical, Inc. CENTRAL INDEX KEY: 0001693587 IRS NUMBER: 273632561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-334964 FILM NUMBER: 19683955 BUSINESS ADDRESS: STREET 1: 16475 DALLAS PARKWAY, SUITE 750 CITY: ADDISON STATE: TX ZIP: TX BUSINESS PHONE: 469-585-7513 MAIL ADDRESS: STREET 1: 16475 DALLAS PARKWAY, SUITE 750 CITY: ADDISON STATE: TX ZIP: TX D 1 primary_doc.xml X0708 D LIVE 0001693587 Vitruvian BioMedical, Inc. 16475 DALLAS PARKWAY, SUITE 750 ADDISON TX TEXAS TX 469-585-7513 DELAWARE None None Corporation true Arthur Bollon, PhD 16475 Dallas Parkway, Suite, 750 Addison TX TEXAS 75001 Executive Officer Founder, CEO and Chairman Pharmaceuticals Decline to Disclose 06b false true false true true true false 25000 4000000 25000 3975000 false 1 0 0 0 false Vitruvian BioMedical, Inc. Arthur Bollon Arthur Bollon, PhD CEO 2018-12-28